Click Therapeutics

New York, New York 10013

0 studies enrolling now · 14 studies all time

What they study most

Atopic Dermatitis, Breast Cancer, Cancer, Covid19, Diabetic Neuropathy, Drug Addiction, Drug Dependence, Episodic Migraine, Fibromyalgia, Headache, Headache, Migraine, Irritable Bowel Syndrome

Studies at this site

• Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia — Completed
• An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia — Completed
• Study of Two Digital Therapeutics for the Prevention of Episodic Migraine — Completed
• Ecological Momentary Assessment and Text Message Intervention for Stress Management — Completed
• A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia — Completed
• An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis — Completed
• An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment with CT-156 in People with Schizophrenia. — Completed
• Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C) — Completed
• An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer — Completed
• Basket Study (CT-100-002) to Evaluate the Effects of a DiNaMo™ Component Training — Completed
• Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms — Completed
• Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification — Withdrawn before enrolling
• Clinical Learning Study for a Mobile Smoking Cessation Program — Completed
• Clinical Trial of Smoking Cessation Mobile Phone Program — Completed